Pharmacokinetics and tissue distribution study of schisandrin B in rats by ultra-fast liquid chromatography with tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 78-79, Issue , 2013, Pages 136-140

  Zhu, Heyun ^a   Zhang, Xiurong ^a   Guan, Jiao ^a   Cui, Baiji ^a   Zhao, Longshan ^b   Zhao, Xu ^b  

^a JILIN MEDICAL COLLEGE   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Pharmacokinetics; Protein precipitation; Schisandrin B; Tissue distribution; UFLC MS MS

Indexed keywords

FORMIC ACID; METHANOL; SCHIZANDRIN B; WATER;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; ELECTROSPRAY; FLOW RATE; FRAGMENTATION REACTION; HEART; KIDNEY; LIQUID CHROMATOGRAPHY; LIVER; LUNG; NONHUMAN; PLASMA; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPLEEN; STANDARD; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; URINARY EXCRETION; VALIDATION STUDY;

ANIMALS; CHROMATOGRAPHY, LIQUID; CYCLOOCTANES; LIGNANS; POLYCYCLIC COMPOUNDS; RATS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84874795188     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.01.041     Document Type: Article

References (17)

1. Pharmacopoeia of the People's Republic of China 2010, China Medical Science Press, Beijing, pp. 61-62.
2. Chiu P.Y., Tang M.H., Ko K.M. Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins. Free Radic. Biol. Med. 2003, 35:368-380.
3. Stacchiotti A., Volti G.L., Rodella L.F. Schisandrin B stimulates a cytoprotective response in rat liver exposed to mercuric chloride. Food Chem. Toxicol. 2009, 47:2834-2840.
4. Chiu Y., Lam P.Y., Ko K.M. Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts. Fitoterapia 2011, 82:682-691.
5. Ip S.P., Ko K.M. The crucial antioxidant action of schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene. Biochem. Pharmacol. 1996, 52:1687-1693.
6. Lam P.Y., Yan C.W., Ko K.M. Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue. Fitoterapia 2011, 82:393-400.
7. Checker R., Patwardhan R.S., Sandur S.K. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kB. Free Radic. Biol. Med. 2012, 53:1421-1430.
8. Li L., Lu Q.H., Hu X. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem. Pharmacol. 2006, 71:584-595.
9. Hu X., Xu Y., Li L. Eur J. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. Cancer Suppl. 2010, 8:62.
10. Lee T.H., Jung C.H., Lee D.H. Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. Food Chem. Toxicol. 2012, 50:4239-4245.
11. Wei H., Sun L.N., Chen W.S. A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera. Anal. Chim. Acta 2010, 662:97-104.
12. Zhang H., Zhang G.Q., Chai Y.F. Determination of six lignans in Schisandra chinensis (Turcz.) Baill. Fruits and related Chinese multiherb remedies by HPLC. Food Chem. 2009, 115:735-739.
13. Wang B.L., Hu J.P., Li Y. Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using liquid chromatography/mass spectrometry. J. Chromatogr. B 2008, 865:114-120.
14. He X.G., Lian L.Z., Lin L.Z. Analysis of lignan constituents from Schisandra chinensis by liquid chromatography-electrospray mass spectrometry. J. Chromatogr. A 1997, 757:81-87.
15. Tang J.J., Shao B., Liu Y. Highly sensitive determination of schisandrin and schisandrin B in plasma of rats after administration of Wurenchun (fructus Schisandrae chinensis Extracts) preparations by LC-ESI-MS/MS. Biomed. Chromatogr. 2010, 24:675-681.
16. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation, 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
17. Shah V.P., Midha K.K., Yacobi A. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res. 2000, 17:1551-1557.